FI63422C - Analogifoerfarande foer framstaellande av nya 21-salicylsyraestrar och 21-acetylsalicylsyraestrar av steroider ur pregnanserien - Google Patents
Analogifoerfarande foer framstaellande av nya 21-salicylsyraestrar och 21-acetylsalicylsyraestrar av steroider ur pregnanserien Download PDFInfo
- Publication number
- FI63422C FI63422C FI773929A FI773929A FI63422C FI 63422 C FI63422 C FI 63422C FI 773929 A FI773929 A FI 773929A FI 773929 A FI773929 A FI 773929A FI 63422 C FI63422 C FI 63422C
- Authority
- FI
- Finland
- Prior art keywords
- salicylate
- hydrogen
- fluoroprednisolone
- general formula
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB54510/76A GB1593978A (en) | 1976-12-31 | 1976-12-31 | Anti-inflammatory steroids |
| GB5451076 | 1976-12-31 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI773929A FI773929A (fi) | 1978-07-01 |
| FI63422B FI63422B (fi) | 1983-02-28 |
| FI63422C true FI63422C (fi) | 1983-06-10 |
Family
ID=10471258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI773929A FI63422C (fi) | 1976-12-31 | 1977-12-27 | Analogifoerfarande foer framstaellande av nya 21-salicylsyraestrar och 21-acetylsalicylsyraestrar av steroider ur pregnanserien |
Country Status (10)
| Country | Link |
|---|---|
| JP (1) | JPS53144561A (fr) |
| BE (1) | BE862507A (fr) |
| CH (1) | CH633301A5 (fr) |
| DK (1) | DK155673C (fr) |
| FI (1) | FI63422C (fr) |
| FR (1) | FR2376160A1 (fr) |
| GB (1) | GB1593978A (fr) |
| NL (1) | NL7714482A (fr) |
| NO (1) | NO148491C (fr) |
| SE (1) | SE430607B (fr) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1440063A (en) * | 1972-08-11 | 1976-06-23 | Glaxo Lab Ltd | 17alpha-esters of 17alpha,21-dihydroxy-20-oxo-steroids |
-
1976
- 1976-12-31 GB GB54510/76A patent/GB1593978A/en not_active Expired
-
1977
- 1977-12-27 FI FI773929A patent/FI63422C/fi not_active IP Right Cessation
- 1977-12-28 NL NL7714482A patent/NL7714482A/xx not_active Application Discontinuation
- 1977-12-28 JP JP15754377A patent/JPS53144561A/ja active Granted
- 1977-12-28 DK DK581677A patent/DK155673C/da not_active IP Right Cessation
- 1977-12-30 CH CH1632977A patent/CH633301A5/de not_active IP Right Cessation
- 1977-12-30 BE BE183990A patent/BE862507A/fr not_active IP Right Cessation
- 1977-12-30 SE SE7714976A patent/SE430607B/sv unknown
- 1977-12-30 FR FR7739817A patent/FR2376160A1/fr active Granted
- 1977-12-30 NO NO774525A patent/NO148491C/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2376160A1 (fr) | 1978-07-28 |
| JPS53144561A (en) | 1978-12-15 |
| DK581677A (da) | 1978-07-01 |
| DK155673C (da) | 1989-09-04 |
| NO774525L (no) | 1978-07-03 |
| NO148491B (no) | 1983-07-11 |
| SE7714976L (sv) | 1978-07-02 |
| NO148491C (no) | 1983-10-19 |
| NL7714482A (nl) | 1978-07-04 |
| FI63422B (fi) | 1983-02-28 |
| JPS6220197B2 (fr) | 1987-05-06 |
| GB1593978A (en) | 1981-07-22 |
| SE430607B (sv) | 1983-11-28 |
| CH633301A5 (en) | 1982-11-30 |
| DK155673B (da) | 1989-05-01 |
| BE862507A (fr) | 1978-04-14 |
| FI773929A (fi) | 1978-07-01 |
| FR2376160B1 (fr) | 1980-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2016350690B2 (en) | Methods for the preparation of obeticholic acid and derivatives thereof | |
| PL179489B1 (pl) | Nowe pochodne prednisolonu, sposób wytwarzania tych pochodnychoraz srodek leczniczy na bazie pochodnych prednisolonu PL PL PL PL PL PL | |
| US20090239833A1 (en) | Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application | |
| PL118567B1 (en) | Process for preparing novel esters of 4-halogen-3-ketoandrosteno-4-carbo-17 betha-thiolic acidosteno-4-karbotiolovojj-17 kisloty | |
| Clayton et al. | Preparation, hydrolysis, and oral absorption of. alpha.-carboxy esters of carbenicillin | |
| GB2039217A (en) | Anti-inflammatory medicaments comprising glycosides of sterols or spiroketal steroids or esters thereof | |
| FI63422C (fi) | Analogifoerfarande foer framstaellande av nya 21-salicylsyraestrar och 21-acetylsalicylsyraestrar av steroider ur pregnanserien | |
| CN101861327B (zh) | 一种抗炎化合物的无定形形式 | |
| US5266566A (en) | Method of treating fungal infections using sterodial ester compounds | |
| IE56022B1 (en) | Pregnane compounds | |
| PL110367B1 (en) | Method of producing new corticoids | |
| US4542141A (en) | Compound having vasodilating, antiaggregating and hypocholesterolemic activities, process for the preparation thereof and pharmaceutical compositions therefrom | |
| EP1658083A1 (fr) | Amelioration de l'activite et de la duree d'action de steroides anti-inflammatoires selectionnes | |
| CA1141751A (fr) | PROCEDE DE PREPARATION D'UN NOUVEAU DERIVE HALOGENE DE LA SERIE DU 16.alpha.-METHYL PREGNANE | |
| JPH0873491A (ja) | トリアムシノロン誘導体 | |
| CN112771063B (zh) | 氟化胆汁酸衍生物 | |
| KR830000630B1 (ko) | 스피로케탈-스테로이드 글리코 사이드의 제조방법 | |
| JPS6249280B2 (fr) | ||
| CS202591B2 (en) | Process for preparing derivatives of 9-fluorprednisolone | |
| US3546261A (en) | Novel ethoxylated acetic acid esters of pregnane-21-ols | |
| IE56400B1 (en) | Novel 6alpha-methylprednisolone derivatives and their manufacture and use | |
| DE2759135A1 (de) | Neue steroidverbindungen und deren herstellung und verwendung | |
| JPS63215695A (ja) | ２１−置換チオステロイド化合物 | |
| CS244147B2 (cs) | Způsob výroby 6<x--methylprednisolonových derivátů | |
| PL127152B1 (en) | Process for preparing novel derivatives of thioethionic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: A. MENARINI S.A.S. Owner name: LARK S.P.A. |